- Also try: Cervical Cancer | Listeria
Lovaxin C Information and News
- Advaxis: Clinical Development: Lovaxin C
- Google News: Lovaxin C
- HealthDay: Experimental Cancer Vaccines Show Promise (April 15, 2008)
- BioPortfolio: Cobra Signs Agreement with Advaxis to Manufacture Lovaxin C Vaccine (October 22, 2007)
- PR Leap: What Women Must Know About Cervical Cancer Vaccines in the News (May 22, 2006)
- Medical News Today: Advaxis Advances Therapeutic Cervical Cancer Vaccine In Effort To Save... (May 9, 2006)
- "The first cancer patients to be treated with an engineered live Listeria vaccine were recently dosed in Advaxis Inc. Phase I/II clinical trial of Lovaxin C, a Listeria-based therapeutic cancer vaccine developed to treat cervical cancer."
- Cancer Compass: Two Leading Biotech Publications Report On Advaxis' Potential... (December 12, 2005)
Lovaxin C Clinical Studies and Research
- PubMed Central Search: Lovaxin C
- This result, Lovaxin C, is currently a stub, a brief collection of the best links for this story. The page will be updated as we find more information.
- Help Mahalo complete this search! Let us know if you've found additional quality links about Lovaxin C on Google, Del.icio.us, Digg or elsewhere, and we can expand this result.
Get Ready for Thanksgiving with Mahalo
